We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+2.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$56.7B
AUM Growth
+$1.08B
(+1.9%)
Cap. Flow
+$547M
Cap. Flow
% of AUM
0.97%
Top 10 Holdings %
Top 10 Hldgs %
8.66%
Holding
2,362
New
158
Increased
1,005
Reduced
951
Closed
174
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FirstEnergy
FE
|
+$185M |
| 2 |
Tyson Foods
TSN
|
+$177M |
| 3 |
Procter & Gamble
PG
|
+$110M |
| 4 |
Entergy
ETR
|
+$101M |
| 5 |
ENDP
Endo International plc
ENDP
|
+$95.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$129M |
| 2 |
Apple
AAPL
|
+$107M |
| 3 |
Abbott
ABT
|
+$99.3M |
| 4 |
AGN
Allergan plc
AGN
|
+$88.8M |
| 5 |
Goldman Sachs
GS
|
+$88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.38% |
| 2 | Financials | 13.11% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 12.63% |
| 5 | Consumer Staples | 11.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
2126
DELISTED
Revance Therapeutics, Inc.
RVNC
| $164K | ﹤0.01% |
12,073
-3,114
| -21% | -$55.1K |
|
|
RXDX
2127
DELISTED
Ignyta, Inc.
RXDX
| $162K | ﹤0.01% |
29,840
| – | – |
|
|
KLDX
2128
DELISTED
KLONDEX MINES LTD
KLDX
| $157K | ﹤0.01% |
+43,525
| New | +$149K |
|
2129
Genworth Financial
GNW
$3.71B
| $153K | ﹤0.01% |
59,419
+16,644
| +39% | +$53.8K |
|
|
TRST
2130
Trustco Bank Corp NY
TRST
$938M
| $153K | ﹤0.01% |
4,793
-7,453
| -61% | -$236K |
|
|
FBR
2131
DELISTED
Fibria Celulose Sa
FBR
| $151K | ﹤0.01% |
22,313
-171,128
| -88% | -$1.46M |
|
|
CMBT
2132
CMB.TECH NV
CMBT
$4.73B
| $150K | ﹤0.01% |
16,406
-17,851
| -52% | -$183K |
|
|
VIVS
2133
VivoSim Labs
VIVS
$1.64M
| $150K | ﹤0.01% |
168
| – | – |
|
|
UAM
2134
DELISTED
Universal American Corp
UAM
| $150K | ﹤0.01% |
19,738
-9,212
| -32% | -$71.4K |
|
|
TTPH
2135
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $149K | ﹤0.01% |
1,737
-527
| -23% | -$48.3K |
|
|
MYCC
2136
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $148K | ﹤0.01% |
11,361
| – | – |
|
|
CALY
2137
Callaway Golf Company
CALY
$3.14B
| $147K | ﹤0.01% |
14,351
| – | – |
|
2138
Trupanion
TRUP
$1.18B
| $146K | ﹤0.01% |
+10,999
| New | +$143K |
|
2139
Azenta
AZTA
$1.48B
| $144K | ﹤0.01% |
12,860
-7,797
| -38% | -$81.7K |
|
2140
AtriCure
ATRC
$2.11B
| $142K | ﹤0.01% |
10,047
-4,932
| -33% | -$75.2K |
|
|
SQBG
2141
DELISTED
Sequential Brands Group, Inc.
SQBG
| $141K | ﹤0.01% |
441
-31
| -7% | -$8.75K |
|
|
TVPT
2142
DELISTED
Travelport Worldwide Limited
TVPT
| $141K | ﹤0.01% |
+10,957
| New | +$147K |
|
|
KBAL
2143
DELISTED
Kimball International
KBAL
| $140K | ﹤0.01% |
12,262
-18,296
| -60% | -$207K |
|
|
TPH
2144
DELISTED
Tri Pointe Homes
TPH
| $139K | ﹤0.01% |
+11,758
| New | +$138K |
|
|
FOE
2145
DELISTED
Ferro Corporation
FOE
| $139K | ﹤0.01% |
10,379
-5,223
| -33% | -$69.2K |
|
2146
Halozyme
HALO
$12.2B
| $135K | ﹤0.01% |
15,629
-10,282
| -40% | -$101K |
|
2147
Insmed
INSM
$28.6B
| $132K | ﹤0.01% |
13,360
| – | – |
|
2148
TransAlta
TAC
$3.93B
| $132K | ﹤0.01% |
+25,480
| New | +$129K |
|
2149
Quantum Corp
QMCO
$474M
| $127K | ﹤0.01% |
1,880
-10,411
| -85% | -$756K |
|
|
SREV
2150
DELISTED
ServiceSource International, Inc.
SREV
| $127K | ﹤0.01% |
31,532
+1,521
| +5% | +$6.04K |
|
Similar funds
VGA
AQR Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, AQR Capital Management held 2,362 positions worth $56.7B, up 1.9% from $55.6B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
AQR Capital Management's Q2 2016 filing shows 158 new, 1,005 increased, 951 reduced and 174 closed positions. Its largest new stake was S&P Global: 466,444 shares worth $50M. The largest sale was Nike, an estimated $129M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.
- AQR Capital Management's largest Q2 2016 buy was S&P Global: 466,444 shares worth $50M.
- AQR Capital Management added most to FirstEnergy in Q2 2016, an estimated $185M increase.
- AQR Capital Management's biggest Q2 2016 reduction was Nike, cutting an estimated $129M.
- AQR Capital Management fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $59.8M.
- AQR Capital Management's ten largest holdings make up 8.7% of its $56.7B portfolio in Q2 2016.
- AQR Capital Management opened 158 new positions and closed 174 in Q2 2016.
- AQR Capital Management's portfolio value rose 1.9% quarter-over-quarter to $56.7B.
Based on AQR Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.